Short-chain fatty acids and trichostatin A alter tight junction permeability in human umbilical vein endothelial cells

Nutrition

Volumn 24, Issue 11-12, 2008, Pages 1189-1198

  Miyoshi, Makoto ^a,b   Usami, Makoto ^a,c   Ohata, Atsushi ^d  

^a KOBE UNIVERSITY   (Japan)

^b KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^c KOBE UNIVERSITY HOSPITAL   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Butyrate; Histone acetylation; Short chain fatty acids; Tight junction permeability; Trichostatin A

Indexed keywords

ACETIC ACID; ANTIESTROGEN; BUTYRIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR; HISTONE DEACETYLASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOXYGENASE INHIBITOR; MESSENGER RNA; PROPIONIC ACID; PROSTAGLANDIN SYNTHASE; TRICHOSTATIN A;

ARTICLE; CELL CULTURE; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION; UMBILICAL VEIN;

ACETATES; BUTYRATES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FATTY ACIDS, VOLATILE; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; LIPOXYGENASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PERMEABILITY; PROPIONATES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TIGHT JUNCTIONS; UMBILICAL VEINS;

BACTERIA (MICROORGANISMS);

EID: 53449083935     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.06.012     Document Type: Article

References (39)

1. Cho M.M., Ziats N.P., Pal D., Utian W.H., and Gorodeski G.I. Estrogen modulates paracellular permeability of human endothelial cells by eNOS- and iNOS-related mechanisms. Am J Physiol Cell Physiol 276 (1999) C337-C349
2. Varma S., Breslin J.W., Lal B.K., Pappas P.J., Hobson R.W., and Duran W.N. p42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvasc Res 63 (2002) 172-178
3. Menconi M.J. Acidosis induces hyperpermeability. Am J Physiol Gastrointest Liver Physiol 272 (1997) G1007-G1021
4. van Hinsbergh W.M. Endothelial permeability for macromolecules. Mechanistic aspects of pathophysiological modulation. Arterioscler Thromb Vasc Biol 17 (1997) 1018-1023
5. Dewi B.E., Takasaki T., and Kurane I. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods 121 (2004) 171-180
6. Hayashi T., Yamada K., Esaki T., Kuzuya M., Satake S., Ishikawa T., et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 214 (1995) 847-855
7. Miller S.J., Zaloga G.P., Hoggatt A.M., Labarrere C., and Faulk W.P. Short-chain fatty acids modulate gene expression for vascular endothelial cell adhesion molecules. Nutrition 21 (2005) 740-748
8. Davis T., Kennedy C., Chiew Y.E., Clarke C.L., and deFazio A. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. Clin Cancer Res 6 (2000) 4334-4342
9. Tappenden K.A., and McBurney M.I. Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes. Dig Dis Sci 43 (1998) 1526-1536
10. Roy C.C., Kien C.L., Bouthillier L., and Levy E. Short-chain fatty acids: ready for prime time?. Nutr Clin Pract 21 (2006) 351-366
11. Drozdowski L.A., Dixon W.T., McBurney M.I., and Thomson A.B. Short-chain fatty acids and total parenteral nutrition affect intestinal gene expression. JPEN 26 (2002) 145-150
12. Conley B.A., Egorin M.J., Tait N., Rosen D.M., Sausville E.A., Dover G., et al. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin Cancer Res 4 (1998) 629-634
13. Schroeder J., Alteheld B., Stehle P., Cayeux M.C., Chiolero R.L., and Berger M.M. Safety and intestinal tolerance of high-dose enteral antioxidants and glutamine peptides after upper gastrointestinal surgery. Eur J Clin Nutr 59 (2005) 307-310
14. Kooistra T., van den Berg J., Tons A., Platenburg G., Rijken D.C., and van den Berg E. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells. Biochem J 247 (1987) 605-612
15. Rossig L., Li H., Fisslthaler B., Urbich C., Fleming I., Forestermann U., et al. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Circ Res 91 (2002) 837-844
16. deFazio A., Chiew Y.E., Donoghue C., Lee C.S., and Sutherland R.L. Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. J Biol Chem 267 (1992) 18008-18012
17. Bordin M., D'Atri F., Guillemot L., and Citi S. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res 2 (2004) 692-701
18. Taniura S., Kamitani H., Watanabe T., and Eling T.E. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. J Biol Chem 277 (2002) 16823-16830
19. Ohata A., Usami M., and Miyoshi M. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation. Nutrition 21 (2005) 838-847
20. Nutting C.W., Islam S., and Daugirdas J.T. Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. Am J Physiol Heart Circ Physiol 261 (1991) H561-H567
21. Sasahara Y., Mutoh M., Takahashi M., Fukuda K., Tanaka N., Sugimura T., et al. Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells. Cancer Lett 177 (2002) 155-161
22. Laubach V.E., Garvey E.P., and Sherman P.A. High-level expression of human inducible nitric oxide synthase in Chinese hamster ovary cells and characterization of the purified enzyme. Biochem Biophys Res Commun 218 (1996) 802-807
23. Schleger C., Platz S.J., and Deschl U. Development of an in vitro model for vascular injury with human endothelial cells. Altex 21 (2004) 12-19
24. Ye L., Martin T.A., Parr C., Harrison G.M., Mansel R.E., and Jiang W.G. Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J Cell Physiol 196 (2003) 362-369
25. Hashida R., Anamizu C., Yagyu-Mizuno Y., Ohkuma S., and Takano T. Transcellular transport of fluorescein dextran through an arterial endothelial cell monolayer. Cell Struct Funct 11 (1986) 343-349
26. Shi L.Z., and Zheng W. Early lead exposure increases the leakage of the blood-cerebrospinal fluid barrier, in vitro. Hum Exp Toxicol 26 (2007) 159-167
27. Galfi P., Neogrady Z., Amberger A., Margreiter R., and Csordas A. Sensitization of colon cancer cell lines to butyrate-mediated proliferation inhibition by combined application of indomethacin and nordihydroguaiaretic acid. Cancer Detect Prev 29 (2005) 276-285
28. Patricia M.K., Natarajan R., Dooley A.N., Hernandez F., Gu J.L., Berliner J.A., et al. Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells. Circ Res 88 (2001) 659-665
29. Fiorucci S., Distrutti E., Mencarelli A., Morelli A., Laufor S.A., Cirino G., et al. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. Br J Pharmacol 139 (2003) 1351-1359
30. Lee Y.W., Kuhn H., Kaiser S., Hennig B., Daugherty A., and Toborek M. Interleukin 4 induces transcription of the 15-lipoxygenase I gene in human endothelial cells. J Lipid Res 42 (2001) 783-791
31. Tamura M., Deb S., Sebastian S., Okamura K., and Bulun S.E. Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells. Fertil Steril 81 (2004) 1351-1356
32. Oviedo P.J., Hermenegildo C., Tarin J.J., and Cano A. Raloxifene promotes prostacyclin release in human endothelial cells through a mechanism that involves cyclooxygenase-1 and -2. Fertil Steril 83 (2005) 1822-1829
33. Wang J., Mahmud S.A., Bitterman P.B., Huo Y., and Slungaard A. Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes. J Biol Chem 282 (2007) 28408-28418
34. Yusta B., Ortiz-Caro J., Bed G., Pascual A., and Aranda A. Regulation of thyroid hormone receptor and c-erbA mRNA levels by butyrate in neuroblastoma (N2A) and glioma (C6) cells. J Neurosci Res 27 (1990) 1-9
35. Rombouts K., Niki T., Greenwel P., Vandermonde A., Wielant A., Hellemans K., et al. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp Cell Res 278 (2002) 184-197
36. Gunin A.G., Kapitova I.N., and Suslonova N.V. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. J Endocrinol 185 (2005) 539-549
37. Arts J., Lansink M., Grimbergen J., Toet K.H., and Kooistra T. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem J 310 (1995) 171-176
38. Robe P.A., Jolois O., N'Guyen M., Princen F., Malgrange B., Merville M.P., and Bours V. Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication. Int J Oncol 25 (2004) 187-192
39. Le Poul E., Loison C., Struyf S., Springael J.Y., Lannoy V., Decobecq M.E., et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278 (2003) 25481-25489